ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 136 filers reported holding ANAPTYSBIO INC in Q3 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $429,000 | -63.6% | 6,731 | -43.1% | 0.54% | -40.7% |
| Q3 2018 | $1,180,000 | +875.2% | 11,823 | +591.8% | 0.90% | +822.4% |
| Q2 2018 | $121,000 | +24.7% | 1,709 | +82.8% | 0.10% | -6.7% |
| Q1 2018 | $97,000 | -82.9% | 935 | -83.4% | 0.10% | -83.9% |
| Q4 2017 | $567,000 | – | 5,628 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |